{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:30:26Z","timestamp":1787729426508,"version":"build-2784847793"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s00392-011-0335-y","type":"journal-article","created":{"date-parts":[[2011,6,18]],"date-time":"2011-06-18T11:16:06Z","timestamp":1308395766000},"page":"1049-1057","source":"Crossref","is-referenced-by-count":146,"title":["Sympatho-renal axis in chronic disease"],"prefix":"10.1007","volume":"100","author":[{"given":"Paul A.","family":"Sobotka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Mahfoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus P.","family":"Schlaich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta C.","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Krum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,19]]},"reference":[{"key":"335_CR1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1152\/japplphysiol.00832.2009","volume":"108","author":"M Esler","year":"2010","unstructured":"Esler M (2010) The 2009 Carl Ludwig Lecture: pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. J Appl Physiol 108:227\u2013237","journal-title":"J Appl Physiol"},{"key":"335_CR2","doi-asserted-by":"crossref","first-page":"R633","DOI":"10.1152\/ajpregu.00258.2005","volume":"289","author":"GF DiBona","year":"2005","unstructured":"DiBona GF (2005) Physiology in perspective: the wisdom of the body. Neural control of the kidney. Am J Physiol Regul Integr Comp Physiol 289:R633\u2013R641","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"Suppl 1","key":"335_CR3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/10641968909045414","volume":"11","author":"M Esler","year":"1989","unstructured":"Esler M, Lambert G, Jennings G (1989) Regional norepinephrine turnover in human hypertension. Clin Exp Hypertens A 11(Suppl 1):75\u201389","journal-title":"Clin Exp Hypertens A"},{"key":"335_CR4","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1161\/01.CIR.0000103123.66264.FE","volume":"108","author":"RJ Huggett","year":"2003","unstructured":"Huggett RJ, Scott EM, Gilbey SG, Stoker JB, Mackintosh AF, Mary DA (2003) Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension. Circulation 108:3097\u20133101","journal-title":"Circulation"},{"key":"335_CR5","first-page":"R298","volume":"260","author":"GF DiBona","year":"1991","unstructured":"DiBona GF, Sawin LL (1991) Role of renal nerves in sodium retention of cirrhosis and congestive heart failure. Am J Physiol 260:R298\u2013R305","journal-title":"Am J Physiol"},{"key":"335_CR6","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1055\/s-0030-1269412","volume":"135","author":"F Mahfoud","year":"2010","unstructured":"Mahfoud F, B\u00f6hm M (2010) Interventional renal sympathetic denervation\u2014a new approach for patients with resistant hypertension. Dtsch Med Wochenschr 135:2422\u20132425","journal-title":"Dtsch Med Wochenschr"},{"key":"335_CR7","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/00004872-200309000-00021","volume":"21","author":"O Vonend","year":"2003","unstructured":"Vonend O, Marsalek P, Russ H, Wulkow R, Oberhauser V, Rump LC (2003) Moxonidine treatment of hypertensive patients with advanced renal failure. J Hypertension 21:1709\u20131717","journal-title":"J Hypertension"},{"key":"335_CR8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/01.HYP.0000103160.35395.9E","volume":"43","author":"MP Schlaich","year":"2004","unstructured":"Schlaich MP, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G, Hastings J, Aggarwal A, Esler MD (2004) Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 43:169\u2013175","journal-title":"Hypertension"},{"key":"335_CR9","first-page":"184","volume":"10","author":"VM Campese","year":"1997","unstructured":"Campese VM (1997) Neurogenic factors and hypertension in chronic renal failure. J Nephrol 10:184\u2013187","journal-title":"J Nephrol"},{"key":"335_CR10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0895-7061(02)02959-X","volume":"15","author":"S Ye","year":"2002","unstructured":"Ye S, Zhong H, Yanamadala V, Campese VM (2002) Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am J Hypertens 15:717\u2013724","journal-title":"Am J Hypertens"},{"key":"335_CR11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.HYP.0000121881.77212.b1","volume":"43","author":"JA Joles","year":"2004","unstructured":"Joles JA, Koomans HA (2004) Causes and consequences of increased sympathetic activity in renal disease. Hypertension 43:699\u2013706","journal-title":"Hypertension"},{"key":"335_CR12","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1161\/01.CIR.0000034043.16664.96","volume":"106","author":"M Hausberg","year":"2002","unstructured":"Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, Dietl KH, Rahn KH (2002) Sympathetic nerve activity in end-stage renal disease. Circulation 106:1974\u20131979","journal-title":"Circulation"},{"key":"335_CR13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/CIRCULATIONAHA.110.971580","volume":"123","author":"H Krum","year":"2011","unstructured":"Krum H, Sobotka P, Mahfoud F, B\u00f6hm M, Esler M, Schlaich M (2011) Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation 123:209\u2013215","journal-title":"Circulation"},{"key":"335_CR14","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMc0904179","volume":"361","author":"MP Schlaich","year":"2009","unstructured":"Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD (2009) Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361:932\u2013934","journal-title":"N Engl J Med"},{"key":"335_CR15","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","volume":"373","author":"H Krum","year":"2009","unstructured":"Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373:1275\u20131281","journal-title":"Lancet"},{"key":"335_CR16","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","volume":"376","author":"MD Esler","year":"2010","unstructured":"Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, B\u00f6hm M (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (the symplicity htn-2 trial): a randomised controlled trial. Lancet 376:1903\u20131909","journal-title":"Lancet"},{"key":"335_CR17","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(10)62111-3","volume":"376","author":"M Doumas","year":"2010","unstructured":"Doumas M, Douma S (2010) Renal sympathetic denervation: the jury is still out. Lancet 376:1878\u20131880","journal-title":"Lancet"},{"key":"335_CR18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1474-8665.2009.00442.x","volume":"29","author":"PJ Fitzgerald","year":"2009","unstructured":"Fitzgerald PJ (2009) Is elevated noradrenaline an aetiological factor in a number of diseases? Auton Autacoid Pharmacol 29:143\u2013156","journal-title":"Auton Autacoid Pharmacol"},{"key":"335_CR19","first-page":"1192","volume":"37","author":"L Barajas","year":"1978","unstructured":"Barajas L (1978) Innervation of the renal cortex. Fed Proc 37:1192\u20131201","journal-title":"Fed Proc"},{"key":"335_CR20","doi-asserted-by":"crossref","first-page":"99S","DOI":"10.1016\/S0895-7061(00)00225-9","volume":"13","author":"M Esler","year":"2000","unstructured":"Esler M (2000) The sympathetic system and hypertension. Am J Hypertens 13:99S\u2013105S","journal-title":"Am J Hypertens"},{"issue":"Suppl 5","key":"335_CR21","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/00005344-198608005-00008","volume":"8","author":"M Esler","year":"1986","unstructured":"Esler M, Jennings G, Biviano B, Lambert G, Hasking G (1986) Mechanism of elevated plasma noradrenaline in the course of essential hypertension. J Cardiovasc Pharmacol 8(Suppl 5):S39\u2013S43","journal-title":"J Cardiovasc Pharmacol"},{"key":"335_CR22","doi-asserted-by":"crossref","first-page":"140S","DOI":"10.1093\/ajh\/2.3.140S","volume":"2","author":"M Esler","year":"1989","unstructured":"Esler M, Jennings G, Lambert G (1989) Noradrenaline release and the pathophysiology of primary human hypertension. Am J Hypertens 2:140S\u2013146S","journal-title":"Am J Hypertens"},{"key":"335_CR23","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.CIR.73.4.615","volume":"73","author":"GJ Hasking","year":"1986","unstructured":"Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI (1986) Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73:615\u2013621","journal-title":"Circulation"},{"key":"335_CR24","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","volume":"52","author":"C Ronco","year":"2008","unstructured":"Ronco C, Haapio M, House AA, Anavekar N, Bellomo R (2008) Cardiorenal syndrome. J Am Coll Cardiol 52:1527\u20131539","journal-title":"J Am Coll Cardiol"},{"key":"335_CR25","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/01.HYP.0000055779.93635.A2","volume":"41","author":"A Aggarwal","year":"2003","unstructured":"Aggarwal A, Esler MD, Morris MJ, Lambert G, Kaye DM (2003) Regional sympathetic effects of low-dose clonidine in heart failure. Hypertension 41:553\u2013557","journal-title":"Hypertension"},{"key":"335_CR26","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/eurheartj\/ehi184","volume":"26","author":"M Petersson","year":"2005","unstructured":"Petersson M, Friberg P, Eisenhofer G, Lambert G, Rundqvist B (2005) Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur Heart J 26:906\u2013913","journal-title":"Eur Heart J"},{"key":"335_CR27","doi-asserted-by":"crossref","unstructured":"Dickstein K (2008) Esc guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. Reply. Eur Heart J 29:2388\u20132442","DOI":"10.1093\/eurheartj\/ehn561"},{"key":"335_CR28","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/01.CIR.0000065187.80707.18","volume":"107","author":"M Gheorghiade","year":"2003","unstructured":"Gheorghiade M, Colucci WS, Swedberg K (2003) Beta-blockers in chronic heart failure. Circulation 107:1570\u20131575","journal-title":"Circulation"},{"key":"335_CR29","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/hc1102.105261","volume":"105","author":"C Zoccali","year":"2002","unstructured":"Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Stancanelli B, Malatino LS (2002) Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 105:1354\u20131359","journal-title":"Circulation"},{"key":"335_CR30","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1681\/ASN.V123602","volume":"12","author":"K Strojek","year":"2001","unstructured":"Strojek K, Grzeszczak W, Gorska J, Leschinger MI, Ritz E (2001) Lowering of microalbuminuria in diabetic patients by a sympathicoplegic agent: novel approach to prevent progression of diabetic nephropathy? JASN 12:602\u2013605","journal-title":"JASN"},{"key":"335_CR31","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1097\/HJH.0b013e32833c2100","volume":"28","author":"M Hausberg","year":"2010","unstructured":"Hausberg M, Tokmak F, Pavenstadt H, Kramer BK, Rump LC (2010) Effects of moxonidine on sympathetic nerve activity in patients with end-stage renal disease. J Hypertension 28:1920\u20131927","journal-title":"J Hypertension"},{"key":"335_CR32","first-page":"2846","volume":"44","author":"RE Katholi","year":"1985","unstructured":"Katholi RE (1985) Renal nerves and hypertension: an update. Fed Proc 44:2846\u20132850","journal-title":"Fed Proc"},{"key":"335_CR33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/ajh\/3.1.62","volume":"3","author":"KP O\u2019Hagan","year":"1990","unstructured":"O\u2019Hagan KP, Thomas GD, Zambraski EJ (1990) Renal denervation decreases blood pressure in doca-treated miniature swine with established hypertension. Am J Hypertens 3:62\u201364","journal-title":"Am J Hypertens"},{"key":"335_CR34","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.HYP.25.4.893","volume":"25","author":"S Kassab","year":"1995","unstructured":"Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP (1995) Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 25:893\u2013897","journal-title":"Hypertension"},{"key":"335_CR35","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/01.HYP.6.5.622","volume":"6","author":"RA Norman Jr","year":"1984","unstructured":"Norman RA Jr, Murphy WR, Dzielak DJ, Khraibi AA, Carroll RG (1984) Role of the renal nerves in one-kidney, one clip hypertension in rats. Hypertension 6:622\u2013626","journal-title":"Hypertension"},{"key":"335_CR36","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/HJH.0b013e328048d004","volume":"25","author":"G Mancia","year":"2007","unstructured":"Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S, Reid J, Van Zwieten PA (2007) The sympathetic nervous system and the metabolic syndrome. J Hypertension 25:909\u2013920","journal-title":"J Hypertension"},{"key":"335_CR37","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","volume":"117","author":"DA Calhoun","year":"2008","unstructured":"Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM (2008) Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association professional education committee of the council for high blood pressure research. Circulation 117:e510\u2013e526","journal-title":"Circulation"},{"key":"335_CR38","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.109.902452","volume":"121","author":"D Yumino","year":"2010","unstructured":"Yumino D, Redolfi S, Ruttanaumpawan P, Su MC, Smith S, Newton GE, Mak S, Bradley TD (2010) Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 121:1598\u20131605","journal-title":"Circulation"},{"key":"335_CR39","doi-asserted-by":"crossref","unstructured":"Witkowski A, Prejbisz A, Florczak E, Kadziela J, Sliwinski P, Bielen P, Michalowska I, Kabat M, Warchol E, Januszewicz M, Narkiewicz K, Somers V, Sobotka P, Januszewicz A (2011) Effects of renal sympathetic denervation on blood pressure in patients with resistant hypertension and sleep apnea\u2014a preliminary report. TRenD Meeting 2011, Frankfurt, Germany","DOI":"10.1161\/HYPERTENSIONAHA.111.173799"},{"key":"335_CR40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.HYP.0000174243.39897.6c","volume":"46","author":"G Grassi","year":"2005","unstructured":"Grassi G, Facchini A, Trevano FQ, Dell\u2019Oro R, Arenare F, Tana F, Bolla G, Monzani A, Robuschi M, Mancia G (2005) Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension 46:321\u2013325","journal-title":"Hypertension"},{"key":"335_CR41","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ajh.2008.263","volume":"22","author":"NK Lima","year":"2009","unstructured":"Lima NK, Abbasi F, Lamendola C, Reaven GM (2009) Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension. Am J Hypertens 22:106\u2013111","journal-title":"Am J Hypertens"},{"key":"335_CR42","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/00004872-199111000-00001","volume":"9","author":"S Julius","year":"1991","unstructured":"Julius S, Gudbrandsson T, Jamerson K, Tariq Shahab S, Andersson O (1991) The hemodynamic link between insulin resistance and hypertension. J Hypertension 9:983\u2013986","journal-title":"J Hypertension"},{"key":"335_CR43","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1161\/CIRCULATIONAHA.110.991869","volume":"123","author":"F Mahfoud","year":"2011","unstructured":"Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Bohm M (2011) Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation 123:1940\u20131946","journal-title":"Circulation"},{"key":"335_CR44","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/HJH.0b013e328344db3a","volume":"29","author":"MP Schlaich","year":"2011","unstructured":"Schlaich MP, Straznicky N, Grima M, Ika-Sari C, Dawood T, Mahfoud F, Lambert E, Chopra R, Socratous F, Hennebry S, Eikelis N, Bohm M, Krum H, Lambert G, Esler MD, Sobotka PA (2011) Renal denervation: a potential new treatment modality for polycystic ovary syndrome? J Hypertension 29:991\u2013996","journal-title":"J Hypertension"},{"key":"335_CR45","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ndt\/gfg584","volume":"19","author":"G Luippold","year":"2004","unstructured":"Luippold G, Beilharz M, Muhlbauer B (2004) Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats. Nephrol Dial Transplant 19:342\u2013347","journal-title":"Nephrol Dial Transplant"},{"key":"335_CR46","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","volume":"311","author":"JN Cohn","year":"1984","unstructured":"Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311:819\u2013823","journal-title":"N Engl J Med"},{"key":"335_CR47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jacc.2009.03.061","volume":"54","author":"JS Floras","year":"2009","unstructured":"Floras JS (2009) Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol 54:375\u2013385","journal-title":"J Am Coll Cardiol"},{"key":"335_CR48","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","volume":"334","author":"M Packer","year":"1996","unstructured":"Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol heart failure study group. N Engl J Med 334:1349\u20131355","journal-title":"N Engl J Med"},{"key":"335_CR49","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","volume":"82","author":"GS Francis","year":"1990","unstructured":"Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (solvd). Circulation 82:1724\u20131729","journal-title":"Circulation"},{"key":"335_CR50","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jacc.2008.11.012","volume":"53","author":"M Jessup","year":"2009","unstructured":"Jessup M, Costanzo MR (2009) The cardiorenal syndrome: do we need a change of strategy or a change of tactics? J Am Coll Cardiol 53:597\u2013599","journal-title":"J Am Coll Cardiol"},{"key":"335_CR51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7326\/0003-4819-113-2-155","volume":"113","author":"RW Schrier","year":"1990","unstructured":"Schrier RW (1990) Body fluid volume regulation in health and disease: a unifying hypothesis. Ann Internal Med 113:155\u2013159","journal-title":"Ann Internal Med"},{"key":"335_CR52","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/bmj.292.6532.1351","volume":"292","author":"H Ring-Larsen","year":"1986","unstructured":"Ring-Larsen H, Henriksen JH, Wilken C, Clausen J, Pals H, Christensen NJ (1986) Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture. Br Med J (Clin Res Ed) 292:1351\u20131353","journal-title":"Br Med J (Clin Res Ed)"},{"key":"335_CR53","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1161\/CIRCULATIONAHA.109.884866","volume":"120","author":"E Di Angelantonio","year":"2009","unstructured":"Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D, Thompson A, Gudnason V, Sattar N, Danesh J (2009) B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation 120:2177\u20132187","journal-title":"Circulation"},{"key":"335_CR54","first-page":"R1599","volume":"266","author":"D Villarreal","year":"1994","unstructured":"Villarreal D, Freeman RH, Johnson RA, Simmons JC (1994) Effects of renal denervation on postprandial sodium excretion in experimental heart failure. Am J Physiol 266:R1599\u2013R1604","journal-title":"Am J Physiol"},{"key":"335_CR55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s380-002-8317-8","volume":"16","author":"T Nozawa","year":"2002","unstructured":"Nozawa T, Igawa A, Fujii N, Kato B, Yoshida N, Asanoi H, Inoue H (2002) Effects of long-term renal sympathetic denervation on heart failure after myocardial infarction in rats. Heart Vessels 16:51\u201356","journal-title":"Heart Vessels"},{"key":"335_CR56","first-page":"H92","volume":"267","author":"H Masaki","year":"1994","unstructured":"Masaki H, Imaizumi T, Harasawa Y, Takeshita A (1994) Dynamic arterial baroreflex in rabbits with heart failure induced by rapid pacing. Am J Physiol 267:H92\u2013H99","journal-title":"Am J Physiol"},{"key":"335_CR57","doi-asserted-by":"crossref","first-page":"F31","DOI":"10.1152\/ajprenal.00088.2010","volume":"300","author":"SC Clayton","year":"2011","unstructured":"Clayton SC, Haack KK, Zucker IH (2011) Renal denervation modulates angiotensin receptor expression in the renal cortex of rabbits with chronic heart failure. Am J Physiol Renal Physiol 300:F31\u2013F39","journal-title":"Am J Physiol Renal Physiol"},{"key":"335_CR58","doi-asserted-by":"crossref","first-page":"R402","DOI":"10.1152\/ajpregu.90772.2008","volume":"296","author":"CD Steinback","year":"2009","unstructured":"Steinback CD, Salzer D, Medeiros PJ, Kowalchuk J, Shoemaker JK (2009) Hypercapnic vs. Hypoxic control of cardiovascular, cardiovagal, and sympathetic function. Am J Physiol Regul Integr Comp Physiol 296:R402\u2013R410","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"335_CR59","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cardfail.2009.08.006","volume":"16","author":"M Chowdhury","year":"2010","unstructured":"Chowdhury M, Adams S, Whellan DJ (2010) Sleep-disordered breathing and heart failure: focus on obstructive sleep apnea and treatment with continuous positive airway pressure. J Card Fail 16:164\u2013174","journal-title":"J Card Fail"},{"key":"335_CR60","doi-asserted-by":"crossref","unstructured":"Holzer-Richling N, Holzer M, Herkner H, Riedmuller E, Havel C, Kaff A, Malzer R, Schreiber W (2011) Randomized placebo controlled trial of furosemide on subjective perception of dyspnoea in patients with pulmonary oedema because of hypertensive crisis. Eur J Clin Invest 41:627\u2013634","DOI":"10.1111\/j.1365-2362.2010.02450.x"},{"key":"335_CR61","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ejheart.2007.07.011","volume":"9","author":"V Hasselblad","year":"2007","unstructured":"Hasselblad V, Gattis Stough W, Shah MR, Lokhnygina Y, O\u2019Connor CM, Califf RM, Adams KF Jr (2007) Relation between dose of loop diuretics and outcomes in a heart failure population: results of the escape trial. Eur J Heart Fail 9:1064\u20131069","journal-title":"Eur J Heart Fail"},{"key":"335_CR62","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00392-008-0732-z","volume":"98","author":"TD Smilde","year":"2009","unstructured":"Smilde TD, Damman K, van der Harst P, Navis G, Westenbrink BD, Voors AA, Boomsma F, van Veldhuisen DJ, Hillege HL (2009) Differential associations between renal function and \u201cmodifiable\u201d risk factors in patients with chronic heart failure. Clin Res Card 98:121\u2013129","journal-title":"Clin Res Card"},{"key":"335_CR63","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000047397","volume":"96","author":"DH Ellison","year":"2001","unstructured":"Ellison DH (2001) Diuretic therapy and resistance in congestive heart failure. Cardiology 96:132\u2013143","journal-title":"Cardiology"},{"key":"335_CR64","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/01.RES.0000145047.14691.db","volume":"95","author":"GF Tomaselli","year":"2004","unstructured":"Tomaselli GF, Zipes DP (2004) What causes sudden death in heart failure? Circ Res 95:754\u2013763","journal-title":"Circ Res"},{"key":"335_CR65","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00392-010-0276-x","volume":"100","author":"S Del Pace","year":"2011","unstructured":"Del Pace S, Parodi G, Bellandi B, Zampini L, Venditti F, Ardito M, Antoniucci D, Gensini GF (2011) Anxiety trait in patients with stress-induced cardiomyopathy: a case-control study. Clin Res Card 100:523\u2013529","journal-title":"Clin Res Card"},{"key":"335_CR66","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","volume":"376","author":"K Swedberg","year":"2010","unstructured":"Swedberg K, Komajda M, B\u00f6hm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L (2010) Ivabradine and outcomes in chronic heart failure (shift): a randomised placebo-controlled study. Lancet 376:875\u2013885","journal-title":"Lancet"},{"key":"335_CR67","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(10)61259-7","volume":"376","author":"M B\u00f6hm","year":"2010","unstructured":"B\u00f6hm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L (2010) Heart rate as a risk factor in chronic heart failure (shift): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 376:886\u2013894","journal-title":"Lancet"},{"key":"335_CR68","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.CIR.71.1.17","volume":"71","author":"AJ Moss","year":"1985","unstructured":"Moss AJ, Schwartz PJ, Crampton RS, Locati E, Carleen E (1985) The long qt syndrome: a prospective international study. Circulation 71:17\u201321","journal-title":"Circulation"},{"key":"335_CR69","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/HYPERTENSIONAHA.109.140665","volume":"55","author":"K Heusser","year":"2010","unstructured":"Heusser K, Tank J, Engeli S, Diedrich A, Menne J, Eckert S, Peters T, Sweep FC, Haller H, Pichlmaier AM, Luft FC, Jordan J (2010) Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension 55:619\u2013626","journal-title":"Hypertension"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00392-011-0335-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T15:59:51Z","timestamp":1637855991000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-011-0335-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,19]]},"references-count":69,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["335"],"URL":"https:\/\/doi.org\/10.1007\/s00392-011-0335-y","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,19]]}}}